MAPT and Lewy body dementia: As differential diagnosis of FTLD-tau from Lewy body disease and FTLD with TDP-43 pathology may be complicated by overlapping clinical symptoms and neuroimaging biomarkers (Duignan et al., 2021), the absence of psychosis may represent a useful indicator of FTLD-tauopathies, potentially resolving some of this diagnostic ambiguity.